MacroGenics

MacroGenics, Inc. is a biotechnology company focused on the development, manufacturing, and commercialization of immunotherapies for autoimmune diseases, cancer, and infectious diseases. The company is developing immune-based products, including monoclonal antibodies as well as vaccines to prevent infections in healthy individuals. Its Fc engineering technology enhances antibody function to eliminate cancer cells. The company is also developing products around its bispecific antibody redirection technology. Founded in 2000, the company is headquartered in Rockville, Maryland.